Patents by Inventor Anita Ranjan Srivastava

Anita Ranjan Srivastava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8063217
    Abstract: A process for preparation of Methyl-(+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester or salts thereof [clopidogrel or salts thereof of Formula (I)] having higher chiral purity and products thereof is provided. A process for purification of the compound prepared is also provided to enhance its efficacy by enhancing its optical rotation and chiral purity. In Formula (I), R is selected from a group comprising alkyl, alkoxy, hydroxy, amine etc., and R1 is selected from the group comprising C1-4 alkyl, C1-4 alkoxy, hydroxy, nitro & halogen. The particular salt of interest of the present invention is the hydrogen sulfate of compound of the Formula (I), wherein R and R1 are —OCH3 and chloro-group at position 2 respectively.
    Type: Grant
    Filed: July 7, 2006
    Date of Patent: November 22, 2011
    Assignee: RPG Life Sciences Limited
    Inventors: Anita Ranjan Srivastava, Prashant Pandurang Pawar, Krishna Anand Poojari, Pravin Chaitram Patil, Rajiv Ramchandra Dalvi
  • Publication number: 20100004453
    Abstract: A process for preparation of Methyl-(+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester or salts thereof [clopidogrel or salts thereof of Formula (I)] having higher chiral purity and products thereof is provided. A process for purification of the compound prepared is also provided to enhance its efficacy by enhancing its optical rotation and chiral purity. In Formula (I), R is selected from a group comprising alkyl, alkoxy, hydroxy, amine etc., and R1 is selected from the group comprising C1-4 alkyl, C1-4 alkoxy, hydroxy, nitro & halogen. The particular salt of interest of the present invention is the hydrogen sulfate of compound of the Formula (I), wherein R and R1 are —OCH3 and chloro-group at position 2 respectively.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 7, 2010
    Applicant: RPG LIFE SCIENCES LIMITED An Indian Company of Ceat Mahal
    Inventors: Anita Ranjan Srivastava, Prashant Pandurang Pawar, Krishna Anand Poojari, Pravin Chaitram Patil, Rajiv Ramchandra Dalvi
  • Patent number: 6639072
    Abstract: A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3-5-diamine (lamotrigine) of the formula I: 2,3-Dichloronitrobenzene in C1-C6 aliphatic alkanol is hydrogenated at 55-90 psi gas pressure using metal catalyst at 27-35° C. 2,3-Dichloroaniline is diazotised and cyano-de-diazonised with metal cyanide at 65-80° C. 2,3-Dichlorobenzonitrile is hydrolysed and 2,3-dichlorobenzoic acid is chlorinated at 55-130° C. Cyano-de-halogenation of 2,3-dichlorobenzoyl chloride is carried out with a metal cyanide and alkali metal iodide by refluxing in an aprotic solvent under an inert atmosphere. 2,3-Dichlorobenzoyl cyanide is condensed with aminoguanidine bicarbonate in an organic solvent in acidic conditions using catalyst at 90-125° C. followed by insitu cyclisation of the Schiff's base by refluxing in an aliphatic alkanol with base. Crude lamotrigine is purified.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: October 28, 2003
    Assignee: RPG Life Sciences Limited
    Inventors: Tarur Venkatasubramanian Radhakrishnan, Thoovara Mohan Sasikumar, Anita Ranjan Srivastava